Matthew Esparza

Matthew Esparza

Auto-generated profile, based on publicly available information

Matthew Esparza

Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
Ke ZhangKe Zhang
Ke Zhang
LMLisa Miorin
Lisa Miorin
TMTadashi Makio
Tadashi Makio
IDIshmael Dehghan
Ishmael Dehghan
SGShengyan Gao
Shengyan Gao
BFBeatriz M.A. Fontoura
Beatriz M.A. Fontoura
SARS-CoV-2 Nsp1 protein binds the mRNA export receptor NXF1-NXT1 to inhibit nuclear export of mRNAs and promote infection.

6 April 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JWJill M. Westcott
Jill M. Westcott
APAmanda M. Prechtl
Amanda M. Prechtl
EMErin A. Maine
Erin A. Maine
TDTuyen Dang
Tuyen Dang
MEMatthew A. Esparza
Matthew A. Esparza
GPGray W. Pearson
Gray W. Pearson
Tumor cells can engage in a process called collective invasion, in which cohesive groups of cells invade through interstitial tissue. Here, we identified an epigenetically distinct subpopulation of breast tumor cells that have an enhanced capacity to collectively invade. Analysis of spheroid invasion in an organotypic culture system revealed that these “trailblazer” cells are capable of initiating collective invasion and promote non-trailblazer cell invasion, indicating a commensal relationship among subpopulations within heterogenous tumors. Canonical mesenchymal markers were not sufficient to distinguish trailblazer cells from non-trailblazer cells, suggesting that defining the molecular underpinnings of the trailblazer phenotype could reveal collective invasion-specific mechanisms. Functional analysis determined that DOCK10, ITGA11, DAB2, PDFGRA, VASN, PPAP2B, and LPAR1 are highly expressed in trailblazer cells and required to initiate collective invasion, with DOCK10 essential for metastasis. In patients with triple-negative breast cancer, expression of these 7 genes correlated with poor outcome. Together, our results indicate that spontaneous conversion of the epigenetic state in a subpopulation of cells can promote a transition from in situ to invasive growth through induction of a cooperative form of collective invasion and suggest that therapeutic inhibition of trailblazer cell invasion may help prevent metastasis.

27 May 2016 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
AMAmir Mor
Amir Mor
AWAlexander White
Alexander White
KZKe Zhang
Ke Zhang
MTMatthew Thompson
Matthew Thompson
MEMatthew Esparza
Matthew Esparza
BFBeatriz M. A. Fontoura
Beatriz M. A. Fontoura

14 September 2015 in Cancer Research
Verified
Journal Article
Closed access
PDF file
TDTuyen Dang
Tuyen Dang
MEMatthew A. Esparza
Matthew A. Esparza
EMErin A. Maine
Erin A. Maine
JWJill M. Westcott
Jill M. Westcott
GPGray W. Pearson
Gray W. Pearson
Cell identity signals influence the invasive capability of tumor cells, as demonstrated by the selection for programs of epithelial-to-mesenchymal transition (EMT) during malignant progression. Breast cancer cells retain canonical epithelial traits and invade collectively as cohesive groups of cells, but the signaling pathways critical to their invasive capabilities are still incompletely understood. Here we report that the transcription factor ΔNp63α drives the migration of basal-like breast cancer (BLBC) cells by inducing a hybrid mesenchymal/epithelial state. Through a combination of expression analysis and functional testing across multiple BLBC cell populations, we determined that ΔNp63α induces migration by elevating the expression of the EMT program components Slug and Axl. Interestingly, ΔNp63α also increased the expression of miR-205, which can silence ZEB1/2 to prevent the loss of epithelial character caused by EMT induction. In clinical specimens, co-expression of various elements of the ΔNp63α pathway confirmed its implication in motility signaling in BLBC. We observed that activation of the ΔNp63α pathway occurred during the transition from noninvasive ductal carcinoma in situ to invasive breast cancer. Notably, in an orthotopic tumor model, Slug expression was sufficient to induce collective invasion of E-cadherin–expressing BLBC cells. Together, our results illustrate how ΔNp63α can drive breast cancer cell invasion by selectively engaging promigratory components of the EMT program while, in parallel, still promoting the retention of epithelial character. Cancer Res; 75(18); 3925–35. ©2015 AACR.

1 July 2019 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
KZKe Zhang
Ke Zhang
YXYihu Xie
Yihu Xie
RMRaquel Munoz-Moreno
Raquel Munoz-Moreno
JWJuan Wang
Juan Wang
LZLiang Zhang
Liang Zhang
YRYi Ren
Yi Ren

2 April 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MEMatthew Esparza
Matthew Esparza
AMAmir Mor
Amir Mor
HNHanspeter Niederstrasser
Hanspeter Niederstrasser
KWKris White
Kris White
AWAlexander White
Alexander White
BFBeatriz M A Fontoura
Beatriz M A Fontoura
Influenza A viruses are human pathogens with limited therapeutic options. Therefore, it is crucial to devise strategies for the identification of new classes of antiviral medications. The influenza A virus genome is constituted of 8 RNA segments. Two of these viral RNAs are transcribed into mRNAs that are alternatively spliced. The M1 mRNA encodes the M1 protein but is also alternatively spliced to yield the M2 mRNA during infection. M1 to M2 mRNA splicing occurs at nuclear speckles, and M1 and M2 mRNAs are exported to the cytoplasm for translation. M1 and M2 proteins are critical for viral trafficking, assembly, and budding. Here we show that gene knockout of the cellular protein NS1-BP, a constituent of the M mRNA speckle-export pathway and a binding partner of the virulence factor NS1 protein, inhibits M mRNA nuclear export without altering bulk cellular mRNA export, providing an avenue to preferentially target influenza virus. We performed a high-content, image-based chemical screen using single-molecule RNA-FISH to label viral M mRNAs followed by multistep quantitative approaches to assess cellular mRNA and cell toxicity. We identified inhibitors of viral mRNA biogenesis and nuclear export that exhibited no significant activity towards bulk cellular mRNA at non-cytotoxic concentrations. Among the hits is a small molecule that preferentially inhibits nuclear export of a subset of viral and cellular mRNAs without altering bulk cellular mRNA export. These findings underscore specific nuclear export requirements for viral mRNAs and phenocopy down-regulation of the mRNA export factor UAP56. This RNA export inhibitor impaired replication of diverse influenza A virus strains at non-toxic concentrations. Thus, this screening strategy yielded compounds that alone or in combination may serve as leads to new ways of treating influenza virus infection and are novel tools for studying viral RNA trafficking in the nucleus. Influenza virus remains a major public health threat killing ~250,000–500,000 people yearly. In pandemic years, influenza infection can lead to even higher mortality rates, as in 1918 when at least 20 million deaths occurred worldwide. Available treatments include vaccines and a few antiviral drugs, but both are limited by mutability of the virus and the development of resistance. Here we leveraged on knowledge of our previous work that uncovered a unique influenza virus pathway inside the nucleus of the host cell, which have the potential to be targeted by a novel therapeutic strategy. We designed and performed a new screen to identify chemical compounds that inhibited viral mRNA production and transport from the nucleus to the cytoplasm of the host cell. Among these compounds, we highlight a novel nuclear export inhibitor of a subset of viral and cellular mRNAs that does not substantially alter bulk cellular RNA export or levels at non-toxic dosages. Consequently, this small molecule inhibits virus replication and therefore can be used as a lead for drug development and serve as an experimental tool for further understanding key steps of the influenza virus mRNA nuclear export pathway.